Współczesna Onkologia

Full text

2/2026 vol. 30
Review paper

Low-grade appendiceal mucinous neoplasm vs. high-grade appendiceal mucinous neoplasm: similarities, differences, and current management challenges

Paweł Lesiak 1
,
Bartosz Kapturkiewicz 1, 2
,
Tomasz Jastrzębski 3, 4
,
Marek Bębenek 1, 2
,
Michał Kazanowski 1, 2

  1. Department of Surgical Oncology, Lower Silesian Center of Oncology, Pulmonology and Haematology, Wroclaw, Poland

  2. Faculty of Medicine, Wroclaw University of Science and Technology, Wroclaw, Poland

  3. Oncological Surgery Department, PCZ Brzeziny Hospital, Brzeziny, Poland

  4. Clinic of Gynaecology and Obstetrics, Medical University of Gdansk, Gdansk, Poland

Contemp Oncol (Pozn) 2026; 30 (2): 110–116

DOI: https://doi.org/10.5114/wo.2026.163813
Data publikacji online: 2026/08/17
Article file
Low-grade.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Carr NJ, Cecil TD, Mohamed F, Sobin LH, Sugarbaker PH, González-Moreno S, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and Associated Appendiceal Neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified Delphi Process. Am J Surg Pathol 2016; 40: 14-26.
  2. Bianco G, Staccini G, Mongelli F, Christoforidis D, Popeskou SG. Is right hemicolectomy ever necessary for low-grade and high-grade appendiceal mucinous neoplasm (LAMN and HAMN)? A systematic review of the literature. Eur J Surg Oncol 2026; 52: 111320.
  3. Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology 2020; 76: 182-188.
  4. Shaib WL, Assi R, Shamseddine A, Alese OB, Staley C, Memis B, et al. Appendiceal mucinous neoplasms: diagnosis and management. Oncologist 2017; 22: 1107-1116.
  5. Bayón LG, Román LM, Lominchar PL. Appendiceal mucinous neoplasms: from clinic to pathology and prognosis. Cancers (Basel) 2023; 15: 3426.
  6. Seldomridge AN, White MG, Scally C, Royal RE, Routbort M, Iorgulescu B, et al. Clinicopathologic and molecular characteristics of high-grade appendiceal mucinous neoplasms. Ann Surg Oncol 2026; 33: 2376-2387.
  7. Gaertner WB, Brown SR, Deutsch M, Jafari MD, Krane MK, Simianu VV, et al. The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Appendiceal Neoplasms. Dis Colon Rectum 2025; 68: 815-834.
  8. Dartigues P, Kepenekian V, Illac-Vauquelin C, Verriele V, Fontaine J, Isaac S, et al. Insights into the clinical prognosis of high-grade appendiceal mucinous neoplasms. Am J Surg Pathol 2025; 49: 499-507.
  9. Ayala-de Miguel C, Jiménez-Castro J, Sánchez-Vegas A, Díaz-López S, Chaves-Conde M. Neoplastic appendiceal mucinous lesions: a narrative review of the literature from an oncologist’s perspective. Clin Transl Oncol 2023; 26: 1287-1299.
  10. Govaerts K, Lurvink RJ, De Hingh IHJT, van der Speeten K, Villeneuve L, Kusamura S, et al. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment. Eur J Surg Oncol 2021; 47: 11-35.
  11. Ballentine SJ, Carr J, Bekhor EY, Sarpel U, Polydorides AD. Updated staging and patient outcomes in low-grade appendiceal mucinous neoplasms. Mod Pathol 2021; 34: 104-115.
  12. Umetsu SE, Kakar S. Issues in assigning the T category in the staging of low-grade appendiceal mucinous neoplasm and high-grade appendiceal mucinous neoplasm. Arch Pathol Lab Med 2023; 147: 1107a-11107.
  13. Chicago Consensus Working Group. The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. Cancer 2020; 126: 2525-2533.
  14. Ibrahim E, Akrmah M, Ligato S. Does a positive appendiceal resection margin in low-grade appendiceal mucinous neoplasms, warrant additional surgery? Our institution experience and literature review. Ann Surg Oncol 2023; 30: 7189-7195.
  15. Solomon D, Bekhor E, Leigh N, Maniar YM, Totin L, Hofstedt M, et al. Surveillance of low-grade appendiceal mucinous neoplasms with peritoneal metastases after cytoreductive surgery and hyper- thermic intraperitoneal chemotherapy: are 5 years enough? A multisite experience. Ann Surg Oncol 2020; 27: 147-153.
  16. Guner M, Aydın C. Low-grade appendiceal mucinous neoplasm: what is the best treatment? Cureus 2023; 15: e46591.
  17. Evans T, Aziz O, Chakrabarty B, Wilson MS, Malcomson L, Lavelle C, et al. Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms. Eur J Surg Oncol 2021; 47: 188-193.
  18. Kusamura S, Levine E, Cinquini M, Glehen O, Piso P, Brandl A, et al. Multisocietal consensus on the use of cytoreductive surgery and HIPEC for the treatment of pseudomyxoma peritonei: a GRADE approach for evidence evaluation and recommendation. J Surg Oncol 2025; 132: 810-816.
  19. Köhler F, Arnold D, Aust D, Betge J, Brecht IB, Germer CT, et al. German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN). Eur J Cancer 2025; 222: 115430.
  20. White MG, Bhutiani N, Helmink BA, Taggart M, Foo WC, Mansfield PF, et al. Treatment variation and long-term outcomes of low-grade appendiceal neoplasms. Ann Surg Oncol 2023; 30: 8138-8143.
  21. Hannan E, Roman LM, O’Brien L, Mueller A, Staunton O, Shields C, et al. Surveillance of low-grade appendiceal mucinous neoplasms for progression to pseudomyxoma peritonei: results from a structured surveillance programme. Colorectal Dis 2025; 27: e17266.
  22. Oravec N, Mack L, Hallock D, McClurg C, Quan ML. A scoping review of postoperative surveillance strategies for localized, low-grade appendiceal mucinous neoplasms. Am J Surg 2025; 242: 116202.
  23. Lohani KR, Sonani H, Buckarma E, Lee HE, Vierkant RA, Thiels CA, et al. Risk stratification of surveillance for low-grade appendiceal mucinous neoplasms. J Gastrointest Surg 2024; 28: 1906-1911.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications